705 results on '"Hasegawa, Mamoru"'
Search Results
2. Apical Vesicles Bearing Inositol 1,4,5-Trisphosphate Receptors in the Ca2+ Initiation Site of Ductal Epithelium of Submandibular Gland
3. Data from TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells
4. ntary Methods, Figure Legends from TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells
5. Supplementary Figures 1 - 7 from TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells
6. BioKnife, a Modified Sendai Virus, to Resect Malignant Tumors
7. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
8. Basic Studies Toward Hematopoietic Stem Cell Gene Therapy
9. Immunogenicity of repeated Sendai viral vector vaccination in macaques
10. Production of Functional Classical Brown Adipocytes from Human Pluripotent Stem Cells using Specific Hemopoietin Cocktail without Gene Transfer
11. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors
12. Modulation of oligosaccharide structure of a pro-urokinase derivative (pro-UKΔGS1) by culture conditions
13. Stable Production of Pro-urokinase and its Derivative by Namalwa KJM-1 Cells Adapted to a Serum-free Medium
14. Toward Gene Therapy for Cystic Fibrosis Using a Lentivirus Pseudotyped With Sendai Virus Envelopes
15. The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways
16. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B
17. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells
18. In vivo imaging of gene transfer to the respiratory tract
19. Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques
20. Transplantation of sendai viral angiopoietin-1-modified mesenchymal stem cells for ischemic limb disease
21. BioKnife, a urokinase-targeted oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma: OR-80.
22. Preclinical long-term safety study of simian immunodeficiency virus (SIV)-based lentiviral vector for retinal gene transfer in non-human primates: OR-44.
23. Diverse subtypes of DCs expressing Ly49D residing are dominantly induced in tumor draining lymph nodes during the regression of in vivo administration of GM-CSF gene transduced lung cancer cells: OR-14.
24. GM-CSF gene-transduced murine cancer stem cells are susceptible to antitumor CD8+ T cell immunity: OR-10.
25. Phase I/IIa, Open-Labeled, Dose Escalation Clinical Study Using FGF-2 Gene Mounted Sendai Virus Vector for Critically Ischemic Limbs: S6-5.
26. Sendai viral vector mediated angiopoietin-1 gene transfer for experimental ischemic limb disease
27. VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-
28. Immunogenicity of DNA and recombinant Sendai virus vaccines expressing the HIV-1 gag gene
29. Sendai Virus-Based Oncolytic Gene Therapy
30. A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia
31. The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization
32. SOC1 inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein
33. Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit
34. Production of recombinant granulocyte colony-stimulating factor by knocking into the active immunoglobulin heavy chain gene locus in the hybridoma cell line
35. Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system
36. Nonstoichiometry of the perovskite-type solid solution La 0.9Ca 0.1Cr 1− yAl yO 3− δ
37. Sendai Virus for Cancer Immunotherapy
38. Assessment of F/HN-Pseudotyped Lentivirus as a Clinically Relevant Vector for Lung Gene Therapy
39. Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma
40. Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: Implications for AIDS vaccine development using Sendai virus vectors
41. Antibiotics II
42. Carbon-Ion Beam Treatment Induces Systemic Antitumor Immunity Against Murine Squamous Cell Carcinoma
43. Comparison of the Expression and Immunogenicity of Wild-Type and Sequence-Modified HIV-1 gag Genes in a Recombinant Sendai Virus Vector
44. Tetrahydrobiopterin-dependent Production of L-DOPA in Genetically Modified Primary Fibroblasts: Basic Research of Gene Therapy for Parkinson's Disease
45. Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus
46. Intrathecal neurokinin-1 receptor antagonist reduces isoflurane MAC in rats
47. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines
48. Novel Treatment for Lithium-Induced Nephrogenic Diabetes Insipidus Rat Model Using the Sendai-Virus Vector Carrying Aquaporin 2 Gene
49. 90. PHARMACOLOGICAL CONTROL OF SENDAI VIRAL TRANSGENE EXPRESSION IN CYNOMOLGUS EMBRYONIC STEM CELLS
50. 38. IN VIVO ANTITUMOR VACCINE EFFECTS OF NONTRANSMISSIBLE SEV ENCODING GM-CSF IN MOUSE RENAL CELL CARCINOMA MODELS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.